-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics to host virtual R&D science forum on inherited retinal disease gene therapies

PUBT·06/02/2026 11:02:44
Listen to the news
Opus Genetics to host virtual R&D science forum on inherited retinal disease gene therapies
  • Opus Genetics will host a virtual R&D Science Forum on June 16, 2026, from 10:00 a.m. to 12:00 p.m. ET.
  • Management, researchers, and invited experts will review its inherited retinal disease gene therapy pipeline.
  • Focus includes RDH12, MERTK, RHO programs nearing clinical testing, with updates from ongoing LCA5 and BEST1 trials.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020700PRIMZONEFULLFEED9729757) on June 02, 2026, and is solely responsible for the information contained therein.